SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥144.43+CN¥1.54 (+1.08%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 17.0% below the high.
Loading market information…
SHZ · 300633.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
SonoScape Medical Corp.’s quoted price sits in the lower half of its reported 52-week range, 27.31% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
SonoScape Medical Corp.’s forward annual dividend is CN¥0.18 per share, paid annual. The forward yield is 0.82% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
SonoScape Medical Corp.’s next earnings report is currently expected on Oct 30, 2026, with estimated earnings per share of -CN¥0.01. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow SonoScape Medical Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
SonoScape Medical Corp. is engaged in the global development and production of medical devices, originating from its base in China. Its comprehensive portfolio includes a diverse range of ultrasound diagnostic systems, encompassing cart-based color Doppler, handheld color Doppler, black and white ultrasound units, and specialized veterinary ultrasound apparatus. The company further provides endoscopy solutions, such as sophisticated image processing equipment, illumination tools, and products tailored for gastroenterological examinations. Beyond its hardware offerings, SonoScape extends crucial support services, including expert technical assistance, component provision, educational programs, system upgrades, and direct field intervention. Established in 2002, SonoScape Medical Corp. maintains its corporate headquarters in Shenzhen, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:45 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 |
|---|
| Apr 25, 2025 |
| CN¥0.160.0% vs estimate |
| CN¥430.00M0.0% vs estimate |
| Q1 2025 | Apr 12, 2025 | CN¥0.07-25.74% vs estimate | CN¥616.00M+1.05% vs estimate |
|---|
| Q3 2024 | Oct 25, 2024 | -CN¥0.14-143.75% vs estimate | CN¥385.51M-9.56% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥144.43+CN¥1.54 (+1.08%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 17.0% below the high.
CN¥48.98+CN¥0.36 (+0.74%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.64% below the high.
HK$51.30+HK$0.65 (+1.28%)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 36.69% below the high.
CN¥182.37+CN¥3.37 (+1.88%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 19.06% below the high.
HK$32.68-HK$0.40 (-1.21%)
Hansoh Pharmaceutical Group Company Limited’s quoted price sits in the lower half of its reported 52-week range, 26.1% below the high.
HK$44.96-HK$0.10 (-0.22%)
WuXi Biologics (Cayman) Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.52% below the high.
CN¥115.92+CN¥0.42 (+0.36%)
Shanghai United Imaging Healthcare Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.16% below the high.
CN¥10.30+CN¥0.04 (+0.39%)
Beijing Wandong Medical Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.53% below the high.
